BioHK 2026
ADVANTAGE AUSTRIA Hong Kong will participate in BIOHK 2026 to showcase Health Metropolis Vienna, one of Europe's leading hubs for healthcare, biotechnology, and medical technology innovation. Joining us are three pioneering Austrian companies, MADx, EVER Pharma, and g.tec medical engineering, each advancing innovation in diagnostics, therapeutics, and neurotechnology. Together, we will highlight Austria's cutting-edge life sciences expertise and explore opportunities for collaboration with Hong Kong's dynamic healthcare and biotech ecosystem.
BIOHK
Date: 9th -12th September 2026
Venue: Hong Kong Convention & Exhibition Centre
Details: https://bio-hk.com/
The ALEX³ test, developed by Austrian company MADx (Macro Array Diagnostics), is an advanced allergy diagnostic solution that provides a comprehensive and highly precise analysis of allergic sensitisation. Using cutting-edge multiplex technology, it delivers a detailed allergy profile from a single blood sample, covering 82 allergen extracts and 218 molecular allergens, making it one of the most comprehensive panels available. Founded in 2016, MADx serves laboratories, hospitals, medical practices, and allergy centres in more than 90 countries, supporting healthcare professionals with accurate, efficient, and patient-friendly diagnostics while advancing the field of molecular allergy testing.
EVER Pharma is a fully integrated specialty pharmaceuticals company dedicated to the research, development, production, and commercialization of products in neurology and specialty injectables, including oncology, intensive care, and hormone therapeutics.
Based in Austria, the company operates a dynamic facility that provides innovative products and value-added formulations aimed at enhancing patients' lives and supporting healthcare professionals through improved convenience and safety.
Products are developed and manufactured at EU GMP certified facilities in Austria and Germany, specializing in complex injectables such as high potency and controlled substances, crystal suspensions, as well as oily solutions in vials, pre-filled syringes, cartridges, implants, and ampoules.
EVER Pharma markets its products in over 70 countries worldwide through international affiliates and strategic partners.
g-tec Medical Engineering GmbH
g.tec medical engineering GmbH has been developing and producing high-performance brain computer interface neuro- technology and CE-certified & FDA cleared medical devices for more than 20 years. g.tec systems are internationally used in clinical or research purposes e.g., analysis of brain, heart or muscle activity, brain assessments of severe brain injuries and disorders of consciousness, stroke neurorehabilitation, neuromarketing, deep brain stimulation, brain mapping, neuro prosthesis-control, communication, painting and closed-loop invasive and non-invasive BCI experiments. g.tec also organizes the yearly BCI Award for the world’s most innovative BCI project and the BCI & Neurotechnology Spring School, a 10-day online event full of scientific talks from BCI experts. The company has sales offices in Hong Kong covering the Asia Pacific region.
g-tec is looking for physiotherapists / nurses / neurologists who are interested in starting a neurorehabilitation franchise business.
Also would like to get in contact with neurosurgeons with an interest in rapid and precise brain mapping for epilepsy and brain tumour patients and university/product development researchers with an interest in high quality brain computer interface and neuromarketing research systems.
Where to meet them:
Austrian booth at BIOHK (3E – D04)
For meeting requests or further information, please contact:
ADVANTAGE AUSTRIA Hong Kong
hongkong@advantageaustria.org